tokens: OBJECTIVE : To perform a cost-effectiveness analysis ( CEA ) between a standard antiemetic regimen-chlorpromazine + dexamethasone ( CPM-DEX ) - and a 5-HT3 receptor antagonist-tropisetron ( TROP ) -- in the control of acute emesis induced by highly emetogenic chemotherapy in children , considering two analytic perspectives : hospital and patients .
folded_tokens: objective : to perform a cost-effectiveness analysis ( cea ) between a standard antiemetic regimen-chlorpromazine + dexamethasone ( cpm-dex ) - and a 5-ht3 receptor antagonist-tropisetron ( trop ) -- in the control of acute emesis induce by highly emetogenic chemotherapy in child , consider two analytic perspective : hospital and patient .